Prenatal maternal dried blood screening with α-fetoprotein and free β-human chorionic gonadotropin for open neural tube defect and Down syndrome
- 29 February 1996
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 174 (2) , 566-572
- https://doi.org/10.1016/s0002-9378(96)70429-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Maternal serum free beta hCG screening: Results of studies including 480 cases of down syndromePrenatal Diagnosis, 1994
- Prenatal Screening for Down's Syndrome with Use of Maternal Serum MarkersNew England Journal of Medicine, 1992
- Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.BMJ, 1992
- Maternal serum Down syndrome screening: Free β-protein is a more effective marker than human chorionic gonadotropinAmerican Journal of Obstetrics and Gynecology, 1990
- Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndromeBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalitiesPrenatal Diagnosis, 1987
- Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha‐fetoprotein levelBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- Critical issues in prenatal maternal serum α-fetoprotein screening for genetic anomaliesAmerican Journal of Obstetrics and Gynecology, 1986
- An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalitiesAmerican Journal of Obstetrics and Gynecology, 1984
- Clinical interpretation of maternal serum α-fetoprotein concentrationsAmerican Journal of Obstetrics and Gynecology, 1984